Skip to main content
logo
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.27
-0.11 (-0.42%)
Sep 24, 2026, 4:00 PM EDT - Market closed

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,3023,5571,6303059011,043
Market Cap Growth
58.49%118.17%434.82%-66.18%-13.58%-14.88%
Enterprise Value
3,1783,4801,508283626681
Last Close Price
26.2729.0413.933.2314.8020.74

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
36.7976.62----
PS Ratio
7.129.468.305.11244.56-
PB Ratio
14.9618.7710.353.444.303.50
P/TBV Ratio
15.9620.3611.013.714.453.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.859.257.674.75169.88-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.520.600.702.320.970.26
Net Debt / Equity Ratio
-0.56-0.56-0.75-0.74-0.99-1.04
Net Debt / EBITDA Ratio
-3.4114.080.940.270.691.50
Net Debt / FCF Ratio
-3.1816.871.050.270.801.76
Asset Turnover
1.100.960.570.150.01-
Inventory Turnover
1.491.981.380.48--
Quick Ratio
2.462.833.726.3811.0611.61
Current Ratio
2.923.174.147.0811.5712.09
Return on Equity (ROE)
15.86%-9.30%-113.76%-175.79%-122.80%-72.62%
Return on Assets (ROA)
5.09%-1.96%-23.25%-38.12%-43.97%-36.55%
Return on Capital Employed (ROCE)
10.40%-4.00%-47.90%-81.80%-73.30%-55.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.86%-0.45%-8.59%-85.99%-34.55%-19.78%
FCF Yield
1.19%-0.18%-6.89%-81.18%-28.63%-16.84%
Buyback Yield / Dilution
-5.07%-5.19%-74.53%-25.94%-11.39%-38.52%
SEC Filings: 10-K · 10-Q